DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

Information source: Far Eastern Memorial Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Asthma

Intervention: Seretide (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Far Eastern Memorial Hospital

Summary

In real life, the investigators will be using different strategies including SMART therapy or other ICS/LABA (medium and high dose) therapy and measure the efficacy for asthma control.

Clinical Details

Official title: Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: the percentage of asthma total and well control

Secondary outcome: percentage of asthma acute exacerbation

Detailed description: 1. All not-well controlled asthma patients would include the study. 2. We will compare three ways of asthma control including SMART, fixed doses with regular doses and fixed doses with higher doses 3. We will evaluate the efficacy/safety for these not-well controlled patients.

Eligibility

Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- asthma not well control

Exclusion Criteria:

- COPD

Locations and Contacts

Additional Information

Starting date: March 2009
Last updated: July 23, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017